EI
EISAI INC.
Organization · NJ
Hires government relations
Who they hire
What they lobby on
General issues related to Medicare and Medicaid, Part D Medicare Program, Part B Medicare Program; Drug Pricing; Centers for Medicare and Medicaid Services (CMS) National Coverage Determination (NCD) for Alzheimers Drugs; H.R. 5376, Inflation Reduction Act of 2022 (PL 117-169) implementation; Center for Medicare and Medicaid Innovation (CMMI) Proposed Accelerated Approval Payment Policy; Center for Medicare and Medicaid Innovation (CMMI) Proposed Rebate Rule.
Issues related to R&D tax credit; H.R.7024, Tax Relief for American Families and Workers Act of 2024.
Regulatory and legislative health care issues, including: Alzheimer's drug development; Drug Pricing; H.R.5378, Lower Costs, More Transparency Act; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; S.3430, Better Mental Health Care Lower-Cost Drugs and Health Extenders Act; S.2973, Modernizing and Ensuring Pharmacy Benefit Managers (PBM) Accountability Act; H.R.2882, Further Consolidated Appropriations Act, 2024, P.L.118-47;improvements to the 340B drug discount program; Seniors Access to Critical Medications Act of 2023.
General issues related to Medicare and Medicaid, Part D Medicare Program, Part B Medicare Program; Drug Pricing; Centers for Medicare and Medicaid Services (CMS) National Coverage Determination (NCD) for Alzheimers therapies; H.R. 5376, Inflation Reduction Act (PL 117-169) implementation; Center for Medicare and Medicaid Innovation (CMMI) Proposed Accelerated Approval Payment Policy; Center for Medicare and Medicaid Innovation (CMMI) Proposed Rebate Rule.
Regulatory and legislative health care issues, including: Alzheimer's drug development; Drug Pricing; H.R.5378, Lower Costs, More Transparency Act; Pandemic and All-Hazards Preparedness Act (PAHPA) including reauthorizing priority review vouchers; S.3430, Better Mental Health Care Lower-Cost Drugs and Health Extenders Act; S.2973, Modernizing and Ensuring Pharmacy Benefit Managers (PBM) Accountability Act; H.R.2882, Further Consolidated Appropriations Act, 2024, P.L.118-47; ; improvements to the 340B drug discount program.